Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul-Aug;119(4):354-359.

A Case-Based Comparison of the American Thyroid Association and Thyroid Imaging Reporting & Data System Guidelines

Affiliations
Review

A Case-Based Comparison of the American Thyroid Association and Thyroid Imaging Reporting & Data System Guidelines

Leslie Shang et al. Mo Med. 2022 Jul-Aug.

Abstract

Thyroid nodules are a common clinical finding. Approximately 4-7% of the population have a palpable nodule on physical exam,1 while up to 70% of the population have a nodule detected incidentally on ultrasound.2 The vast majority of nodules are benign, however, approximately 5-13% of thyroid nodules detected on imaging are at risk of malignancy.3 Some malignant nodules, especially those smaller than 1 cm, can exhibit indolent behavior and do not require aggressive treatment.4 Therefore, thyroid nodules need to be accurately assessed to avoid overdiagnosis and overtreatment of nodules which would not otherwise affect patient morbidity. The American Thyroid Association (ATA) addressed this challenge by developing a set of ultrasound pattern-based guidelines for thyroid nodule management in 2009, which were updated in 2015.5 Other societies have since published similar guidelines, such as the Thyroid Imaging Reporting & Data System (TI-RADS) by the American College of Radiology in 2017. TI-RADS was similarly intended to risk-stratify nodules based on ultrasound appearance, but uses a points-based approach. The purpose of this review is to provide an overview of thyroid nodule evaluation and management through a case-based comparison using the ATA and TI-RADS guidelines.

PubMed Disclaimer

Conflict of interest statement

Disclosure None reported.

References

    1. Burman KD, Wartofsky L. Thyroid Nodules. New Engl J Medicine. 2015;373(24):2347–2356. doi: 10.1056/nejmcp1415786. - DOI - PubMed
    1. Wong R, Farrell SG, Grossmann M. Thyroid nodules: diagnosis and management. Med J Australia. 2018;209(2):92–98. doi: 10.5694/mja17.01204. - DOI - PubMed
    1. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. Jama. 2018;319(9):914–924. doi: 10.1001/jama.2018.0898. doi: 10.1001/jama.2018.3696. Erratum in Jama. 2018; 319(15)1622. - DOI - DOI - PubMed
    1. Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. Journal of the American College of Radiology. 2017;14(5):587–595. doi: 10.1016/j.jacr.2017.01.046. - DOI - PubMed
    1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015;26(1):1–133. doi: 10.1089/thy.2015.0020. - DOI - PMC - PubMed

LinkOut - more resources